RPRX logo

Royalty Pharma plc (RPRX) Cash from financing

annual CFF:

$356.04M+$2.52B(+116.47%)
December 31, 2024

Summary

  • As of today (September 9, 2025), RPRX annual cash flow from financing activities is $356.04 million, with the most recent change of +$2.52 billion (+116.47%) on December 31, 2024.
  • During the last 3 years, RPRX annual CFF has risen by +$15.14 million (+4.44%).
  • RPRX annual CFF is now -74.92% below its all-time high of $1.42 billion, reached on December 31, 2020.

Performance

RPRX Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

quarterly CFF:

-$507.81M+$433.49M(+46.05%)
June 30, 2025

Summary

  • As of today (September 9, 2025), RPRX quarterly cash flow from financing activities is -$507.81 million, with the most recent change of +$433.49 million (+46.05%) on June 30, 2025.
  • Over the past year, RPRX quarterly CFF has dropped by -$1.66 billion (-143.91%).
  • RPRX quarterly CFF is now -132.15% below its all-time high of $1.58 billion, reached on June 30, 2020.

Performance

RPRX quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

TTM CFF:

-$2.03B-$1.66B(-452.10%)
June 30, 2025

Summary

  • As of today (September 9, 2025), RPRX TTM cash flow from financing activities is -$2.03 billion, with the most recent change of -$1.66 billion (-452.10%) on June 30, 2025.
  • Over the past year, RPRX TTM CFF has dropped by -$1.39 billion (-214.27%).
  • RPRX TTM CFF is now -230.67% below its all-time high of $1.56 billion, reached on June 30, 2020.

Performance

RPRX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RPRX Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+116.5%-143.9%-214.3%
3 y3 years+4.4%-122.5%-625.3%
5 y5 years+129.9%-132.2%-230.7%

RPRX Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+116.5%-143.9%+62.6%-624.9%+6.9%
5 y5-year-74.9%+116.5%-132.2%+62.6%-230.7%+6.9%
alltimeall time-74.9%+116.5%-132.2%+62.6%-230.7%+6.9%

RPRX Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$507.81M(-46.1%)
-$2.03B(+452.1%)
Mar 2025
-
-$941.30M(+264.9%)
-$368.16M(-201.9%)
Dec 2024
$356.04M(-116.5%)
-$257.96M(-20.7%)
$361.14M(-6.7%)
Sep 2024
-
-$325.50M(-128.1%)
$387.21M(-159.9%)
Jun 2024
-
$1.16B(-645.6%)
-$646.77M(-69.9%)
Mar 2024
-
-$212.00M(-8.6%)
-$2.15B(+0.1%)
Dec 2023
-$2.16B(+127.0%)
-$231.89M(-82.9%)
-$2.15B(-1.5%)
Sep 2023
-
-$1.36B(+291.8%)
-$2.18B(+107.3%)
Jun 2023
-
-$347.00M(+64.9%)
-$1.05B(+12.7%)
Mar 2023
-
-$210.37M(-20.8%)
-$934.26M(-1.1%)
Dec 2022
-$952.05M(-379.3%)
-$265.55M(+15.4%)
-$944.86M(+7.7%)
Sep 2022
-
-$230.09M(+0.8%)
-$877.38M(-326.7%)
Jun 2022
-
-$228.25M(+3.3%)
$386.98M(-1.0%)
Mar 2022
-
-$220.97M(+11.6%)
$390.82M(+1.5%)
Dec 2021
$340.90M
-$198.07M(-119.2%)
$385.11M(+25.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
$1.03B(-560.9%)
$305.79M(-128.2%)
Jun 2021
-
-$224.41M(-1.0%)
-$1.09B(-251.2%)
Mar 2021
-
-$226.67M(-18.3%)
$717.98M(-51.7%)
Dec 2020
$1.42B(-219.1%)
-$277.39M(-22.4%)
$1.49B(+0.6%)
Sep 2020
-
-$357.39M(-122.6%)
$1.48B(-4.9%)
Jun 2020
-
$1.58B(+191.1%)
$1.56B(-565.5%)
Mar 2020
-
$542.52M(-289.8%)
-$334.15M(-72.0%)
Dec 2019
-$1.19B(-13.6%)
-$285.80M(+1.8%)
-$1.19B(+31.6%)
Sep 2019
-
-$280.69M(-9.5%)
-$905.82M(+44.9%)
Jun 2019
-
-$310.18M(-1.5%)
-$625.13M(+98.5%)
Mar 2019
-
-$314.96M
-$314.96M
Dec 2018
-$1.38B(+1018.9%)
-
-
Dec 2017
-$123.25M(-86.7%)
-
-
Dec 2016
-$923.32M(>+9900.0%)
-
-
Dec 2015
-$6.75M
-
-

FAQ

  • What is Royalty Pharma plc annual cash flow from financing activities?
  • What is the all time high annual CFF for Royalty Pharma plc?
  • What is Royalty Pharma plc annual CFF year-on-year change?
  • What is Royalty Pharma plc quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly CFF year-on-year change?
  • What is Royalty Pharma plc TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM CFF year-on-year change?

What is Royalty Pharma plc annual cash flow from financing activities?

The current annual CFF of RPRX is $356.04M

What is the all time high annual CFF for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cash flow from financing activities is $1.42B

What is Royalty Pharma plc annual CFF year-on-year change?

Over the past year, RPRX annual cash flow from financing activities has changed by +$2.52B (+116.47%)

What is Royalty Pharma plc quarterly cash flow from financing activities?

The current quarterly CFF of RPRX is -$507.81M

What is the all time high quarterly CFF for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cash flow from financing activities is $1.58B

What is Royalty Pharma plc quarterly CFF year-on-year change?

Over the past year, RPRX quarterly cash flow from financing activities has changed by -$1.66B (-143.91%)

What is Royalty Pharma plc TTM cash flow from financing activities?

The current TTM CFF of RPRX is -$2.03B

What is the all time high TTM CFF for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cash flow from financing activities is $1.56B

What is Royalty Pharma plc TTM CFF year-on-year change?

Over the past year, RPRX TTM cash flow from financing activities has changed by -$1.39B (-214.27%)
On this page